Sells instruments, consumables and services for mass cytometry, spatial biology and genomic research to academic, clinical research and biopharmaceutical customers.
10-K for FY2025, filed Mar 16, 2026At Standard BioTools, Inc. ("Standard BioTools" or the "Company"), we are committed to setting the new standard in the life science tools…View ↗
Our CyTOF technology platform transforms single-cell analysis by leveraging mass cytometry to detect and quantify over 50 intracellular and…View ↗
Our Hyperion spatial biology platform unlocks deeper insights into tissue organization by preserving spatial context while enabling…View ↗
Our Biomark X9 system redefines high-throughput genomics by delivering exceptional efficiency, precision, and scalability for qPCR…View ↗
We sell our instruments and consumables for research use only ("RUO") to leading academic research institutions, translational research and…View ↗
The company sells instruments and consumables to academic and translational research institutions, research and cancer labs, and biopharma and biotech firms through its direct sales force and, in some countries, distributors or sales agents.
10-K for FY2025, filed Mar 16, 2026
10-K for FY2025, filed Mar 16, 2026
One genomics customer accounted for 12%, 12%, and 10% of the Company's total revenue for the years ended December 31, 2025, 2024, and 2023…View ↗
No. It lost $74.9M in FY2025.
10-Q for Q3 FY2026, filed Nov 3, 2026
$13.5MView ↗
10-Q for Q3 FY2026, filed Nov 3, 2026
Open tableView ↗
8-K, filed Nov 3, 2026
On November 3, 2026, Standard BioTools Inc., a Delaware corporation (“Standard BioTools”), issued a joint press release with ARCHIMED, a…View ↗
8-K, filed Sep 30, 2026
On September 30, 2026, following termination of the Multiplex Bio Purchase Agreement, the Company entered into a Share and Asset Purchase…View ↗
8-K, filed Aug 5, 2026
Standard BioTools is withdrawing its full year 2026 revenue outlook given the pending merger with Treeline Biosciences.View ↗
8-K, filed Jun 8, 2026
On June 6, 2026, Standard BioTools Inc., a Delaware corporation (“Standard BioTools”), entered into an Agreement and Plan of Merger and…View ↗
Loading...